Advertisement

Journal of Thrombosis and Thrombolysis

, Volume 43, Issue 3, pp 426–427 | Cite as

ST-elevation no myocardial infarction

  • Peter DammanEmail author
  • Robbert J. de Winter
  • Mitchell W. Krucoff
Letter to the Editor
  • 99 Downloads

Acute coronary syndrome encompasses a clinical spectrum of signs and symptoms and that are most commonly caused by intracoronary atherosclerotic plaque rupture or erosion with superimposed thrombus formation and distal embolization [1]. This intracoronary thrombus may lead to (partial) occlusion of the artery and a reduction in blood flow leading to clinical symptoms such as chest pain. Despite the common pathophysiological substrate, the clinical presentation of ACS is diverse. It ranges from ST-segment elevation myocardial infarction (STEMI), where the coronary artery is totally occluded by thrombus, to non-ST-segment elevation acute coronary syndrome characterized by a partially or intermittently occlusive thrombus. ST-segment elevation on electrocardiography, indicating but not limited to complete coronary occlusion, is the clinical hallmark of ST-elevation myocardial infarction (STEMI). Although myocardial cell injury can occur after 20–30 min of ischemia, it takes several hours...

Keywords

Primary Percutaneous Coronary Intervention Coronary Occlusion Myocardial Necrosis Collateral Blood Flow Elevation Acute Coronary Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Compliance with ethical standards

Conflict of interest

None with regards to this article.

Research involving human rights

This article does not contain any studies with human participants performed by any of the authors.

References

  1. 1.
    Davies MJ (2000) The pathophysiology of acute coronary syndromes. Heart 83(3):361–366CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Verheugt FW, Gersh BJ, Armstrong PW (2006) Aborted myocardial infarction: a new target for reperfusion therapy. Eur Heart J 27(8):901–904CrossRefPubMedGoogle Scholar
  3. 3.
    Krucoff MW, Johanson P, Baeza R, Crater SW, Dellborg M (2004) Clinical utility of serial and continuous ST-segment recovery assessment in patients with acute ST-elevation myocardial infarction: assessing the dynamics of epicardial and myocardial reperfusion. Circulation 110(25):e533–e539CrossRefPubMedGoogle Scholar
  4. 4.
    Sabia PJ, Powers ER, Ragosta M, Sarembock IJ, Burwell LR, Kaul S (1992) An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med 327(26):1825–1831CrossRefPubMedGoogle Scholar
  5. 5.
    Rittersma SZ, van der Wal AC, Koch KT, Piek JJ, Henriques JP, Mulder KJ, Ploegmakers JP, Meesterman M, de Winter RJ (2005) Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention. Circulation 111(9):1160–1165CrossRefPubMedGoogle Scholar
  6. 6.
    Krucoff MW (2009) From ST-elevation myocardial infarction to ST elevation with no myocardial infarction–review and overview of a new horizon of computerized electrocardiographic ischemia detection using high-fidelity implantable devices. J Electrocardiol 42(6):487–493CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Peter Damman
    • 1
    Email author
  • Robbert J. de Winter
    • 1
  • Mitchell W. Krucoff
    • 2
  1. 1.Department of Cardiology (B2-213)Academic Medical Center – University of AmsterdamAmsterdamThe Netherlands
  2. 2.Duke University Medical CenterDuke Clinical Research InstituteDurhamUSA

Personalised recommendations